Finally, antiviral drug for dengue in the offing
World’s first botanical drug against dengue is in the final stage of development at the Delhi-based International Centre for Genetic …
When generics turn into Big Pharma
Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims
Sun Pharma to buy troubled giant Ranbaxy
The combined entity will create India’s largest pharma company and world’s fifth-largest specialty generics company
Karnataka receives lowest solar energy tariff bid till date
Sun Pharma bags solar project by quoting Rs 5.51 per unit; previous lowest bid was for Rs 7 in Odisha
Sun-Ranbaxy merger: CCI says deal may hurt competition, seeks public opinion
The merger would lead to creation of the world's fifth-largest maker of generic drugs
Sun Pharma, Novartis settle lawsuit over Glivec
Sun Pharma allowed to launch generic version of anti-leukamia drug next year
Pharma lobby obtains stay on Centre’s drug price control order
Drug manufacturers also trying to scuttle government’s drug pricing policy